Joshi Abhay
Insider CIK 1359089 · RVNC Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-03-15 | 2022-03-17 | 2,607 | $15.79 | $41.2K | 120,708 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-02-15 | 2022-02-17 | 2,902 | $13.35 | $38.7K | 123,315 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-02-15 | 2022-02-17 | 2,151 | $13.35 | $28.7K | 126,217 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-03-15 | 2021-03-17 | 1,354 | $27.73 | $37.5K | 128,368 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-02-15 | 2021-02-19 | 1,967 | $28.97 | $57.0K | 132,603 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-02-15 | 2021-02-19 | 2,881 | $28.97 | $83.5K | 129,722 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-02-02 | 2021-02-04 | 40,925 | — | $0 | 40,925 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-02-02 | 2021-02-04 | 22,620 | — | $0 | 134,570 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-09-30 | 2020-10-02 | 7,382 | $25.14 | $185.6K | 111,950 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-09-30 | 2020-10-02 | 17,500 | — | $0 | 119,332 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-03-15 | 2020-03-17 | 1,354 | $15.50 | $21.0K | 101,832 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-02-15 | 2020-02-19 | 3,325 | $25.33 | $84.2K | 103,186 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-01-23 | 2020-01-24 | 146,500 | — | $0 | 146,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-01-23 | 2020-01-24 | 25,000 | — | $0 | 106,511 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-01-15 | 2020-01-17 | 4,441 | $22.89 | $101.7K | 81,511 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-12-14 | 2019-12-17 | 2,971 | $15.99 | $47.5K | 85,952 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-03-15 | 2019-03-18 | 1,354 | $15.45 | $20.9K | 88,923 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2019-03-14 | 2019-03-18 | 666 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-03-14 | 2019-03-18 | 166 | $15.59 | $2.6K | 90,277 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2019-03-14 | 2019-03-18 | 666 | $4.20 | $2.8K | 90,443 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-02-15 | 2019-02-20 | 1,510 | $17.69 | $26.7K | 89,777 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2019-01-24 | 2019-01-25 | 94,000 | — | $0 | 94,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2019-01-24 | 2019-01-25 | 15,750 | — | $0 | 91,287 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-01-15 | 2019-01-17 | 4,466 | $20.19 | $90.2K | 75,537 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2018-12-14 | 2018-12-14 | 4,260 | $19.91 | $84.8K | 80,003 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2018-03-21 | 2018-03-23 | 666 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2018-03-21 | 2018-03-23 | 666 | $2.55 | $1.7K | 84,263 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2018-02-15 | 2018-02-16 | 1,509 | $31.75 | $47.9K | 83,597 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2018-02-08 | 2018-02-09 | 70,500 | — | $0 | 70,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2018-02-08 | 2018-02-09 | 11,750 | — | $0 | 85,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2018-01-15 | 2018-01-17 | 4,327 | $34.50 | $149.3K | 73,356 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2017-12-14 | 2017-12-18 | 3,229 | $32.15 | $103.8K | 77,683 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2017-01-26 | 2017-01-30 | 79,000 | — | $0 | 79,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2017-01-26 | 2017-01-30 | 13,100 | — | $0 | 80,912 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2016-12-15 | 2016-12-16 | 36,000 | — | $0 | 67,812 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2016-12-14 | 2016-12-16 | 3,229 | $16.70 | $53.9K | 31,812 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2016-08-12 | 2016-08-16 | 666 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2016-08-12 | 2016-08-16 | 666 | $6.60 | $4.4K | 35,041 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-12-14 | 2015-12-16 | 206,250 | — | $0 | 206,250 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2015-12-14 | 2015-12-16 | 34,375 | — | $0 | 34,375 | SEC↗ |